A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

NCT07227831 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer
Hormone Receptor Positive Tumor
Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DEVICE: TheraBionic P1

Sponsor

Barbara Ann Karmanos Cancer Institute